Neurocrine Biosciences
NBIX
#1416
Rank
โ‚น1.074 T
Marketcap
โ‚น10,609
Share price
1.42%
Change (1 day)
18.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น229.40 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚น229.40 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น185.81 B31.48%
2022-12-31$โ‚น141.32 B38.19%
2021-12-31$โ‚น102.26 B24.17%
2020-12-31$โ‚น82.36 B81.35%
2019-12-31$โ‚น45.41 B35.11%
2018-12-31$โ‚น33.61 B41.47%
2017-12-31$โ‚น23.76 B11.05%
2016-12-31$โ‚น21.39 B-24.14%
2015-12-31$โ‚น28.20 B113.26%
2014-12-31$โ‚น13.22 B77.81%
2013-12-31$โ‚น7.43 B-11.99%
2012-12-31$โ‚น8.45 B165.94%
2011-12-31$โ‚น3.17 B266.65%
2010-12-31$โ‚น0.86 B372.49%
2009-12-31$โ‚น0.18 B-89.62%
2008-12-31$โ‚น1.76 B-62.06%
2007-12-31$โ‚น4.65 B-66.58%
2006-12-31$โ‚น13.93 B-20.6%
2005-12-31$โ‚น17.55 B2.92%
2004-12-31$โ‚น17.05 B-4.22%
2003-12-31$โ‚น17.80 B65.59%
2002-12-31$โ‚น10.75 B-28.2%
2001-12-31$โ‚น14.97 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น167.59 B-26.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น822.80 B 258.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น9.41 Million-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.208 T 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น575.52 B 150.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.422 T 3,135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น40.55 B-82.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.08 Billion-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA